| Tatiana Stephanoff, MD | |
|
6301 Mountain Vista St Ste 205, Henderson, NV 89014-2366 | |
| (702) 614-5437 | |
| (702) 990-9922 |
| Full Name | Tatiana Stephanoff |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 6301 Mountain Vista St Ste 205, Henderson, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053410639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 11489 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tatiana Stephanoff, MD 6301 Mountain Vista St Ste 205, Henderson, NV 89014-2366 Ph: (702) 614-5437 | Tatiana Stephanoff, MD 6301 Mountain Vista St Ste 205, Henderson, NV 89014-2366 Ph: (702) 614-5437 |
News Archive
The authors explain this detour by showing that an attractant protein that normally directs T cells into the gut is aberrantly produced in the liver during PSC. T cells expressing the receptor for the protein are thus re-routed to the liver
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac MRI, according to a study being presented today at the annual meeting of the Radiological Society of North America.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.
› Verified 5 days ago
Emily K Peterson, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 10001 S Eastern Ave Ste 101, Henderson, NV 89052 Phone: 702-616-5870 | |
Dr. Jagannath Surpure, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 W Sunset Rd Ste A, Henderson, NV 89014 Phone: 702-898-6400 Fax: 702-898-7032 | |
Laura F Teisch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2350 West Horizon Ridge Parkway, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 | |
Rosemary Y Hyun, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2350 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 | |
Dr. Stella Maris Delgado-almenario, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2510 Wigwam Pkwy, Suite 103, Henderson, NV 89074 Phone: 702-558-3551 Fax: 702-361-0983 | |
Natasa Mihic, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 871 Coronado Center Dr Ste 141, Henderson, NV 89052 Phone: 702-566-2400 Fax: 702-433-2477 |